or Try an Advanced Search...

    Technical Analysis for SNSE - Sensei Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.60 -4.05% -0.03
    SNSE closed down 4.05 percent on Monday, July 1, 2024, on 10 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SNSE trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    20 DMA Resistance Bearish -4.05%
    Down 3 Days in a Row Weakness -4.05%
    20 DMA Resistance Bearish -10.51%
    Fell Below 20 DMA Bearish -11.05%
    Wide Bands Range Expansion -11.05%
    Crossed Above 20 DMA Bullish -18.38%
    Wide Bands Range Expansion -18.38%
    Older End-of-Day Signals for SNSE ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 10 hours ago
    Down 1% about 10 hours ago
    Rose Above 20 DMA 3 days ago
    10 DMA Support 3 days ago
    60 Minute Opening Range Breakout 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SNSE Chart by TradingView
    Basic chart:

    Profile

    Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, engages in the discovery and development of therapies with an initial focus on treatments for cancer. The company develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response. It is engineering ImmunoPhage product candidates to directly target antigen presenting cells and modulate the tumor microenvironment through the targeted use of nanobodies which further enhances therapeutic activity. Sensei Biotherapeutics, Inc. was formerly known as Panacea Pharmaceuticals, Inc. The company was founded in 1999 and is headquartered in Rockville, Maryland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Immunotherapy Tumor Cancer Immunotherapy Virotherapy

    Is SNSE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 30 Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
    May 24 Sensei stock plunges 46% in wake of Phase 1 data
    May 23 Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
    May 9 Sensei Biotherapeutics GAAP EPS of -$0.32
    May 9 Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
    Apr 24 Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
    Apr 9 Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference
    Apr 4 Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment
    Mar 22 Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
    Mar 6 Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
    See more SNSE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.94
    52 Week Low 0.51
    Average Volume 285,738
    200-Day Moving Average 0.86
    50-Day Moving Average 1.03
    20-Day Moving Average 0.66
    10-Day Moving Average 0.64
    Average True Range 0.09
    RSI (14) 35.90
    ADX 33.59
    +DI 13.50
    -DI 24.77
    Chandelier Exit (Long, 3 ATRs) 0.55
    Chandelier Exit (Short, 3 ATRs) 0.86
    Upper Bollinger Bands 0.74
    Lower Bollinger Band 0.58
    Percent B (%b) 0.11
    BandWidth 24.26
    MACD Line -0.11
    MACD Signal Line -0.13
    MACD Histogram 0.0198
    Fundamentals Value
    Market Cap 14.87 Million
    Num Shares 25 Million
    EPS -1.32
    Price-to-Earnings (P/E) Ratio -0.45
    Price-to-Sales 0.00
    Price-to-Book 0.29
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.64
    Resistance 3 (R3) 0.64 0.63 0.63
    Resistance 2 (R2) 0.63 0.62 0.63 0.63
    Resistance 1 (R1) 0.61 0.61 0.61 0.61 0.63
    Pivot Point 0.60 0.60 0.60 0.60 0.60
    Support 1 (S1) 0.58 0.59 0.58 0.58 0.56
    Support 2 (S2) 0.57 0.58 0.57 0.56
    Support 3 (S3) 0.55 0.57 0.56
    Support 4 (S4) 0.55